MACROCHEM CORPORATION


Jul 24, 08

NEW STORY
08:00 ET MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis

 
Jun 05, 08

08:00 ET MacroChem Announces Presentation by Michael Zasloff, MD, PhD on Topical Therapy for Diabetic Foot Infection

 
Apr 23, 08

08:00 ET MacroChem Acquires Virium Pharmaceuticals

 
Mar 19, 08

10:29 ET MacroChem Appoints David P. Luci as New CFO

 
Mar 13, 08

09:11 ET MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection

 
Dec 06, 07

14:03 ET David Luci Joins MacroChem as General Counsel and Vice President Corporate Development

 
Dec 05, 07

14:11 ET MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York

 
Nov 06, 07

08:00 ET MacroChem Announces Positive Interim Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis

 
Oct 30, 07

10:00 ET MacroChem CEO to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference November 6, 2007 in New York City

 
Oct 17, 07

08:00 ET MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Company's Scientific Advisory Board

 
Oct 16, 07

13:50 ET MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City

 
Oct 10, 07

08:00 ET MacroChem Announces Preferred Stock Conversions and $3.5 Million Private Placement

 
Oct 04, 07

08:00 ET MacroChem CEO to Host Open House Presentation at BioPartnering Europe Conference

 
Oct 03, 07

13:18 ET MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

 
Jul 10, 07

08:00 ET Macrochem Acquires Option To License Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infection, from Genaera

 
May 10, 07

10:30 ET MacroChem CEO Provides Update on Product and Business Strategy at Annual Shareholders' Meeting

 
May 08, 07

08:30 ET MacroChem CEO to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference

 
May 01, 07

11:30 ET MacroChem CEO to Present at BIO Annual International Convention on May 8 in Boston

 
Apr 11, 07

08:00 ET MacroChem Completes Patient Enrollment for Phase II Trial of Econail(TM) for Treatment of Onychomycosis

 
Feb 21, 07

08:30 ET MacroChem to Present at the Equities Magazine Emerging Growth Stock Day Conference XIV on February 23, 2007

 
Feb 08, 07

08:58 ET MacroChem to Present at the BIO CEO & Investor Conference 2007

 
Nov 28, 06

08:34 ET MacroChem to Present at the Equities Magazine Discovery Day Corporate Conference December 1, 2006

 
Nov 02, 06

14:00 ET MacroChem to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006 in New York City

 
09:36 ET MacroChem to Present at the PIPEs Conference on November 7, 2006 in New York City

 
Oct 03, 06

08:30 ET MacroChem Initiates Phase II Trial of EcoNail(TM) Topical Antifungal Lacquer

 
Sep 14, 06

14:38 ET MacroChem Retains The Investor Relations Group

 
10:52 ET MacroChem to Present at the Equities Magazine Transatlantic Corporate Conference 2006

 
Jun 12, 06

09:00 ET MacroChem CEO to Present at Wall Street Analyst Forum 17th Annual Analyst Conference on June 14th

 
May 18, 06

10:53 ET MacroChem CEO Provides Update on Product and Business Strategy at Annual Shareholders' Meeting

 
May 10, 06

10:41 ET MacroChem CEO to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference

 
Apr 26, 06

12:38 ET MacroChem CEO to Present at RedChip Small-Cap Conference on April 28, 2006

 
Apr 07, 06

08:00 ET MacroChem CEO to Present at Massachusetts Pavilion at BIO Annual International Convention on April 11 in Chicago

 
Feb 13, 06

12:12 ET MacroChem Raises Additional $5.75 Million in Second Closing of Private Placement with Institutional Investors

 
Feb 10, 06

09:24 ET MacroChem Announces Reverse Stock Split

 
Jan 05, 06

09:50 ET MacroChem Announces Reverse Stock Split and Appointment of Two New Directors

 
Dec 28, 05

13:53 ET MacroChem Announces $2.5 Million Private Placement with Institutional Investors

 
Nov 21, 05

09:10 ET MacroChem Delisted from Quotation on Nasdaq Capital Market

 
Oct 24, 05

14:45 ET MacroChem Appeals Nasdaq Delisting Determination

 
Sep 01, 05

10:33 ET MacroChem Discontinues Research and Product Development Activities, Terminates Substantially all Non-Management Personnel, Will Seek Buyer for Company or its Assets

 
Jun 14, 05

10:00 ET MacroChem CEO Reports on Year of Progress and Innovation at Annual Shareholders' Meeting

 
May 12, 05

09:02 ET MacroChem Reports Positive Results From Clinical Trial of Opterone(R) Topical Testosterone Cream*

    
May 06, 05

07:30 ET MacroChem Presents EcoNail(TM) Clinical Data at Society for Investigative Dermatology Annual Meeting (1)

    
Apr 20, 05

08:05 ET MacroChem Completes Private Placement

 
08:04 ET MacroChem Granted Extension to Regain Compliance With Nasdaq Minimum Bid Price Requirement

 
Apr 07, 05

08:31 ET MacroChem to Present EcoNail(TM) Clinical Data at Society For Investigative Dermatology Meeting

 
Apr 01, 05

17:28 ET MacroChem Corporation Complies With Nasdaq Rule Regarding Recently Filed 10-K

 
Feb 22, 05

09:00 ET MacroChem CEO to Participate in Industry Panel on Sexual Dysfunction and Hormone Therapies

 
Dec 08, 04

09:01 ET MacroChem Announces Initiation of Next Clinical Trial of Opterone(R), First Testosterone Cream For Male Hypogonadism

 
Nov 16, 04

09:02 ET MacroChem Announces Successful Results From EcoNail(TM) Clinical Trial in Patients with Onychomycosis

 
Nov 15, 04

09:41 ET MacroChem CEO will Present at NY Society of Security Analysts' Conference on Investing in Specialty Pharmaceuticals & Biotech, November 16 in New York

 
Nov 03, 04

14:58 ET MacroChem CEO to Present at MASSOPPS Biotechnology Investment Conference, November 5 in Boston

 
Oct 26, 04

08:01 ET MacroChem CEO Will Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 28 in New York

 
Oct 14, 04

06:01 ET MacroChem CEO to Present at Bio 'Emerging Company Investor Forum' on October 15 in San Francisco

 
Oct 06, 04

04:00 ET MacroChem to Present at Drug Delivery Global Summit- Evaluating Emerging Technologies in London

 
Aug 03, 04

08:10 ET MacroChem Announces Clinical Trial Results of First Topical Testosterone Cream

 
Jul 30, 04

15:58 ET MacroChem to Host Conference Call and Webcast

 
Jun 23, 04

10:00 ET MacroChem Reports on Clinical Trial Progress at Annual Shareholder Meeting

 
Jun 07, 04

11:46 ET MacroChem CEO to Present at BIO 2004 Business Forum

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2008 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.